NPPES file of Aug 9, 2026

Rachel Fetner, M.D.

Endocrinology, Diabetes & Metabolism Physician · Great Neck, NY

Rachel Fetner, M.D. is an endocrinology, diabetes & metabolism physician with a practice address in Great Neck, New York, and NPI 1437184850, issued on Jul 12, 2006. Check the license (New York 223909, as entered in NPPES) on the NYS Education Department, Office of the Professions; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1437184850
Name
Rachel Fetner
Credential
M.D.
Primary taxonomy
Endocrinology, Diabetes & Metabolism Physician 207RE0101X
License number
223909 NY
Self-reported in NPPES; status is on the state search
Practice location
29 Barstow RD, Great Neck, NY 11021
Phone
(516) 482-0347
Enumerated
Jul 12, 2006
Record last updated
Jul 8, 2007 (not updated in 19 years: call before relying on the address or phone)
Fax
(516) 482-3267
Medicare enrollment
Enrolled (PECOS I20050110000753); accepts Medicare assignment
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 29 Barstow RD

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Beatrice Barer, LCSWClinical Social Worker1356499123
  2. Barbara Berkowitz, LCSWClinical Social Worker1326039884
  3. Diane Capezza, L.C.S.W.Clinical Social Worker1326119793
  4. Valerie Clain, CSWClinical Social Worker1407838600
  5. Susan Coven, D.D.S.Periodontics1003218421
  6. Colleen DecuirAudiologist1831348531

Verify Rachel Fetner in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersNYS Education Department, Office of the Professions
    Search for license 223909
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the New York license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

23% fewer Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024

2,031 Medicare Part D claims for 400 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 52% of claims.

  1. Rachel Fetner2,031
  2. Specialty average2,630

Most prescribed

  1. Levothyroxine Sodium223 claims
  2. Metformin Hcl156 claims
  3. Synthroid128 claims
  4. Lantus Solostar90 claims
  5. Nano 2nd Gen Pen Needle86 claims
  6. Mounjaro85 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 88.8 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualityout of 100 · 30% of the final score100.0
  2. Costout of 100 · 30%50.6
  3. Promoting interoperabilitynot scored (reweighted)
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $1,519.24

76 payments; by number, the most common kind was food and beverage; the largest payer was Lilly USA, LLC. The 5,661 providers of this specialty with any payment received $5,742.15 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Rachel Fetner$1,519.24
  2. Specialty average$5,742.15

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. Chs Physician Partners PCRoslyn, NY

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Rachel Fetner among 970 endocrinology, diabetes & metabolism physician records in New York

Rachel Fetner, M.D. is one of 970 endocrinology, diabetes & metabolism physician records with a practice address in New York. 86% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 9% of them.

  • NPI issued2006 · 9% of these records are older, 57% newer
  • In a Medicare fileYes · 86% of these records are
  • In the CMS Doctors and Clinicians fileYes · 72% of these records are
  • Graduated2000 · median 2004 among the 694 with a school on file
  • Record last updated2007 · 59% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a New York practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Endocrinology, Diabetes & Metabolism Physician providers in New York

There are 970 endocrinology, diabetes & metabolism physician records in New York.

The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes

  1. Yigal Aharon, MDGreat Neck, NY 110211598739393
  2. Ronda Bloom, MDGreat Neck, NY 110211447210703
  3. Ailian Chen, MDGreat Neck, NY 110211831298801
  4. Tina Constantin, M.D.Great Neck, NY 110211083903561
  5. Seth Friedman, MDGreat Neck, NY 110211053389916
  6. Yael Harris, MDGreat Neck, NY 110211164663357
  7. Jonathan Kaplan, MDGreat Neck, NY 110211285713487
  8. Alan Kluger, M.D.Great Neck, NY 110211952395683

Common questions

What is Rachel Fetner, M.D.'s NPI number?

Rachel Fetner, M.D.'s National Provider Identifier (NPI) is 1437184850, issued on Jul 12, 2006. An NPI identifies a provider in billing; it is not a license.

Where is Rachel Fetner, M.D. located?

The NPPES record lists a practice address at 29 Barstow RD, Great Neck, NY, 11021. Phone: (516) 482-0347. Providers update this record themselves, so call before visiting.

How can I verify Rachel Fetner, M.D.'s license?

NPPES lists New York license number 223909, as entered by the provider. Search the NYS Education Department, Office of the Professions at https://www.op.nysed.gov/services/verifications/online-verification-searches. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Rachel Fetner, M.D. prescribe under Medicare Part D?

In 2024, Rachel Fetner, M.D. had 2,031 Medicare Part D claims for 400 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.

What is Rachel Fetner, M.D.'s MIPS final score?

The 2023 MIPS final score is 88.8 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.